These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 6201264

  • 1. Activation of cytotoxic activity of human blood lymphocytes by tumor-promoting compounds.
    Ramos OF, Masucci MG, Klein E.
    Cancer Res; 1984 May; 44(5):1857-62. PubMed ID: 6201264
    [Abstract] [Full Text] [Related]

  • 2. The tumor promoter phorbol-12,13-dibutyrate [P(Bu)2] stimulates cytotoxic activity of human blood lymphocytes.
    Ramos OF, Masucci MG, Bejarano MT, Klein E.
    Immunobiology; 1983 Dec; 165(5):403-14. PubMed ID: 6607208
    [Abstract] [Full Text] [Related]

  • 3. Phorbol esters enhance spontaneous cytotoxicity of human lymphocytes, abrogate Fc receptor expression, and inhibit antibody-dependent lymphocyte-mediated cytotoxicity.
    Trinchieri G, O'Brien T, Shade M, Perussia B.
    J Immunol; 1984 Oct; 133(4):1869-77. PubMed ID: 6432902
    [Abstract] [Full Text] [Related]

  • 4. Phorbol ester-inactivation of cloned cytotoxic T lymphocytes: restoration of lytic activity by interleukin 2 and induction of interferon production are separable events.
    Finke JH, Yen-Lieberman B, Scott JW, Proffitt MR, Orosz CG.
    Lymphokine Res; 1985 Oct; 4(4):299-308. PubMed ID: 3930891
    [Abstract] [Full Text] [Related]

  • 5. Phorbol esters inhibit the functional activation of cytotoxic precursors in mixed lymphocyte cultures.
    Masucci MG, Torsteinsdottir S, Pear W, Carstensen A, Klein E.
    J Immunol; 1984 Oct; 133(4):1755-62. PubMed ID: 6236256
    [Abstract] [Full Text] [Related]

  • 6. Modulation of human blood lymphocyte cytotoxicity by the phorbol ester tumor promoter P(Bu)2: increase of target binding, impairment of effector recycling, and activation of lytic potential which is independent of IL-2.
    Ramos OF, Masucci MG, Klein E.
    Cell Immunol; 1985 Mar; 91(1):178-92. PubMed ID: 3871663
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters.
    Laskin DL, Laskin JD, Kessler FK, Weinstein IB, Carchman RA.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4523-8. PubMed ID: 7306973
    [Abstract] [Full Text] [Related]

  • 8. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A, Nowicky JW.
    Drugs Exp Clin Res; 1996 Nov; 22(3-5):103-13. PubMed ID: 8899312
    [Abstract] [Full Text] [Related]

  • 9. Increase in the synthesis of a Mr 32,000 protein in BALB/c 3T3 cells treated with tumor-promoting indole alkaloids or polyacetates.
    Hiwasa T, Fujiki H, Sugimura T, Sakiyama S.
    Cancer Res; 1983 Dec; 43(12 Pt 1):5951-5. PubMed ID: 6416671
    [Abstract] [Full Text] [Related]

  • 10. Augmentation of natural killer cell activity by lipopolysaccharide through separable effects on the binding of nonadherent lymphocytes to tumor targets and tumor killing.
    Salata RA, Kleinhenz ME, Schacter BZ, Ellner JJ.
    Cancer Res; 1984 Mar; 44(3):1044-7. PubMed ID: 6607107
    [Abstract] [Full Text] [Related]

  • 11. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
    Ritter M, Huber C, Auböck J, Pohl-Markl H, Troppmair J, Herold M, Gächter A, Nussbaumer W, Böck G, Nachbaur D.
    Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
    [Abstract] [Full Text] [Related]

  • 12. Suppression of the cytotoxic response of mouse lymphocytes to syngeneic tumor cells by tumor-promoting phorbol ester.
    Fredrickson GG, Bennett M.
    Cancer Res; 1982 Sep; 42(9):3601-6. PubMed ID: 7105034
    [Abstract] [Full Text] [Related]

  • 13. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
    Gomez MJ, Torosantucci A, Quinti I, Testa U, Peschle C, Cassone A.
    Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
    [Abstract] [Full Text] [Related]

  • 14. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
    Vose BM, Bonnard GD.
    J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
    [Abstract] [Full Text] [Related]

  • 15. Phorbol ester-induced lymphocyte adherence: selective action on NK cells.
    Argov S, Hebdon M, Cuatrecasas P, Koren HS.
    J Immunol; 1985 Apr; 134(4):2215-22. PubMed ID: 3855930
    [Abstract] [Full Text] [Related]

  • 16. Synergistic effects of IL-7 and IL-12 on human T cell activation.
    Mehrotra PT, Grant AJ, Siegel JP.
    J Immunol; 1995 May 15; 154(10):5093-102. PubMed ID: 7730615
    [Abstract] [Full Text] [Related]

  • 17. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro.
    Ghoneum M, Jewett A.
    Cancer Detect Prev; 2000 May 15; 24(4):314-24. PubMed ID: 11059563
    [Abstract] [Full Text] [Related]

  • 18. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y, Suzuki Y, Katakura R, Miyagi T, Yamaguchi T, Yoshimoto T, Ebina T.
    Clin Cancer Res; 1997 Apr 15; 3(4):633-43. PubMed ID: 9815731
    [Abstract] [Full Text] [Related]

  • 19. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12.
    Cesano A, Visonneau S, Clark SC, Santoli D.
    J Immunol; 1993 Sep 15; 151(6):2943-57. PubMed ID: 8104216
    [Abstract] [Full Text] [Related]

  • 20. Erythromyeloid tumor cells (K562) induce PGE synthesis in human peripheral blood monocytes.
    Leung KH, Fischer DG, Koren HS.
    J Immunol; 1983 Jul 15; 131(1):445-9. PubMed ID: 6575096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.